drugset / Trial / NCT00336167
Bezafibrate Trial in CPT2 Deficiency
Phase 3
Unknown
12 enrolled
Assistance Publique - Hôpitaux de Paris
Association Française contre les Myopathies (AFM), Paris · collabInstitut National de la Santé Et de la Recherche Médicale, France · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether bezafibrate is effective in the treatment of the muscular adult form of carnitine palmitoyltransferase 2 deficiency
Timeline
- Start
- 2006-06
- Primary completion
- —
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bezafibrate | Small molecule | 400 mg | — |
| Subject | Bezafibrate | Small molecule | 600 mg | — |